|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| NET SALES | |||||
| COST OF GOODS SOLD | |||||
| Gross profit | |||||
| OPERATING EXPENSES: | |||||
| Engineering, research and development | |||||
| Selling, general and administrative | |||||
| Severance expense | |||||
| Impairment Charges | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| OTHER INCOME: | |||||
| Investment (loss) income, net | |||||
| Other, net | |||||
| Total other (loss) income | |||||
| Income before provision for income taxes | |||||
| PROVISION FOR INCOME TAXES | |||||
| NET INCOME | |||||
| Less: Net loss attributable to non-controlling interests | |||||
| NET INCOME ATTRIBUTABLE TO GENTEX CORPORATION | |||||
| EARNINGS PER SHARE ATTRIBUTABLE TO GENTEX CORPORATION: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Cash Dividends Declared per Share (in dollars per share) |
Loading...